Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia

Immune thrombocytopenia (ITP) and chronic myeloid leukemia (CML) are rarely observed concurrently. Here we report the case of a patient with ITP who developed CML that has been well controlled with tyrosine kinase inhibitor (TKI) therapy. A 55-year-old man was diagnosed with ITP. No cytogenetic abno...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Yuichi, Itoh, Yoshihiro, Wakimoto, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661458/
https://www.ncbi.nlm.nih.gov/pubmed/36374396
http://dx.doi.org/10.1007/s12185-022-03492-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661458/
https://www.ncbi.nlm.nih.gov/pubmed/36374396
http://dx.doi.org/10.1007/s12185-022-03492-9

Ejemplares similares